MEDINET Co., Ltd. (TYO:2370)
Japan · Delayed Price · Currency is JPY 26.00
+1.00 (4.00%)
Aug 6, 2026, 1:03 PM JST
MEDINET Market Cap
MEDINET has a market cap or net worth of 7.04 billion as of August 5, 2026. Its market cap has decreased by -30.00% in one year.
Market Cap
7.04B
Enterprise Value
n/a
Revenue
998.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.00
ChartMarket Cap Chart
Since December 20, 2005, MEDINET's market cap has decreased from 41.58B to 7.04B, a decrease of -83.07%. That is a compound annual growth rate of -8.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 7.04B | -8.28% |
| Dec 30, 2025 | 7.68B | -19.38% |
| Dec 30, 2024 | 9.52B | -11.95% |
| Dec 29, 2023 | 10.81B | -28.06% |
| Dec 30, 2022 | 15.03B | 64.34% |
| Dec 30, 2021 | 9.15B | -8.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nano Holdings | 8.35B |
| OncoTherapy Science | 8.16B |
| Kidswell Bio | 7.45B |
| StemCell Institute | 7.35B |
| BrightPath Biotherapeutics | 7.08B |
| ADR Biomedical Holdings | 7.08B |
| Carna Biosciences | 6.32B |
| CellSource | 6.11B |